van Oost B, van Hien-Hagg I H, Timmermans A P, Sixma J J
Blood. 1983 Aug;62(2):433-8.
The buoyant density of human platelets is decreased after they have been aggregated and induced to secrete their granule content by thrombin. This change in density was detected by discontinuous density gradient centrifugation using arabinogalactan (Stractan) solutions. The density decrease was dependent on the thrombin concentration and paralleled the extent of serotonin and beta-thromboglobulin secretion. The degranulated platelets maintained their integrity, and many of their functional properties. Mixtures of degranulated platelets and normal platelets could be resolved by Stractan gradient centrifugation and the number of degranulated platelets quantitated. Using this method, increased levels of less dense platelets were shown to occur after cardiopulmonary bypass. Assay of changes in platelet density by Stractan gradient centrifugation is a useful method for detection of activated platelets in vitro and in vivo.
人血小板在被凝血酶聚集并诱导其分泌颗粒内容物后,其浮力密度会降低。这种密度变化通过使用阿拉伯半乳聚糖(Stractan)溶液的不连续密度梯度离心法检测到。密度降低取决于凝血酶浓度,并与5-羟色胺和β-血小板球蛋白的分泌程度平行。脱颗粒血小板保持其完整性及其许多功能特性。脱颗粒血小板和正常血小板的混合物可以通过Stractan梯度离心法分离,并且可以对脱颗粒血小板的数量进行定量。使用这种方法,显示体外循环后低密度血小板水平增加。通过Stractan梯度离心法测定血小板密度变化是一种在体外和体内检测活化血小板的有用方法。